Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and urmc-099

atazanavir sulfate has been researched along with urmc-099 in 3 studies

Compound Research Comparison

Studies
(atazanavir sulfate)		Trials
(atazanavir sulfate)		Recent Studies (post-2010)
(atazanavir sulfate)		Studies
(urmc-099)		Trials
(urmc-099)		Recent Studies (post-2010) (urmc-099)
1,10224659021020

Protein Interaction Comparison

ProteinTaxonomyatazanavir sulfate (IC50)urmc-099 (IC50)
Serine/threonine-protein kinase Sgk1Homo sapiens (human)0.201
Inhibitor of nuclear factor kappa-B kinase subunit betaHomo sapiens (human)0.257
Aurora kinase AHomo sapiens (human)0.108
Inhibitor of nuclear factor kappa-B kinase subunit alphaHomo sapiens (human)0.591
5'-AMP-activated protein kinase subunit beta-2Homo sapiens (human)1.512
Rho-associated protein kinase 2Homo sapiens (human)0.111
Tyrosine-protein kinase ABL1Homo sapiens (human)0.0049
High affinity nerve growth factor receptorHomo sapiens (human)0.085
Insulin receptorHomo sapiens (human)0.2
Tyrosine-protein kinase LckHomo sapiens (human)0.333
Cyclin-dependent kinase 1Homo sapiens (human)1.125
Insulin-like growth factor 1 receptorHomo sapiens (human)0.307
Hepatocyte growth factor receptorHomo sapiens (human)0.177
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)4.33
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.039
Cyclin-dependent kinase 2Homo sapiens (human)1.18
Mitogen-activated protein kinase 1Homo sapiens (human)6.29
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.282
Tyrosine-protein kinase ZAP-70Homo sapiens (human)5.05
Tyrosine-protein kinase SYKHomo sapiens (human)0.731
Mitogen-activated protein kinase 8Homo sapiens (human)3.24
5'-AMP-activated protein kinase subunit gamma-1Homo sapiens (human)1.512
5'-AMP-activated protein kinase catalytic subunit alpha-2Homo sapiens (human)1.512
Mitogen-activated protein kinase kinase kinase 9Homo sapiens (human)0.019
Protein delta homolog 1Homo sapiens (human)0.15
Mitogen-activated protein kinase kinase kinase 10Homo sapiens (human)0.042
5'-AMP-activated protein kinase catalytic subunit alpha-1Homo sapiens (human)1.512
Rho-associated protein kinase 1Homo sapiens (human)1.03
Mitogen-activated protein kinase kinase kinase 11Homo sapiens (human)0.014
BDNF/NT-3 growth factors receptorHomo sapiens (human)0.217
Leucine-rich repeat serine/threonine-protein kinase 2Homo sapiens (human)0.011
Mitogen-activated protein kinase kinase kinase 11Mus musculus (house mouse)0.46
Aurora kinase BHomo sapiens (human)0.123
5'-AMP-activated protein kinase subunit gamma-3Homo sapiens (human)1.512
5'-AMP-activated protein kinase subunit gamma-2Homo sapiens (human)1.512
TRAF2 and NCK-interacting protein kinaseHomo sapiens (human)0.0052
Aurora kinase CHomo sapiens (human)0.29
Mitogen-activated protein kinase kinase kinase 2Homo sapiens (human)0.661
5'-AMP-activated protein kinase subunit beta-1Homo sapiens (human)1.512

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araínga, M; Ciborowski, P; Dash, PK; Gelbard, HA; Gendelman, HE; Goodfellow, VS; Gorantla, S; Guo, D; Haverland, NA; Knibbe-Hollinger, J; Liu, XM; Martinez-Skinner, A; McMillan, JM; Poluektova, LY; Wiederin, JL; Wysocki, BJ; Wysocki, TA; Zhang, G1
Alnouti, Y; Bade, AN; Dash, PK; Edagwa, B; Gautam, N; Gelbard, HA; Gendelman, HE; Gnanadhas, DP; Gorantla, S; Lin, Z; McMillan, J; Mosley, RL; Palandri, DL; Sillman, B1
Dash, PK; Edagwa, B; Gelbard, H; Gendelman, HE; Gnanadhas, DP; Gorantla, S; Lin, Z; Machhi, J; McMillan, J; Thomas, MB1

Other Studies

3 other study(ies) available for atazanavir sulfate and urmc-099

ArticleYear
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.
    Nanomedicine : nanotechnology, biology, and medicine, 2016, Volume: 12, Issue:1

    Topics: Animals; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; MAP Kinase Kinase Kinases; Mice; Mice, SCID; Mitogen-Activated Protein Kinase Kinase Kinase 11; Nanocapsules; Protein Kinase Inhibitors; Pyridines; Pyrroles; Treatment Outcome

2016
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs.
    The Journal of clinical investigation, 2017, Mar-01, Volume: 127, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Female; Heterocyclic Compounds, 3-Ring; HIV-1; Humans; Macrophages; Male; Mice; Nanoparticles; Oxazines; Piperazines; Pyridines; Pyridones; Pyrroles

2017
Modulating cellular autophagy for controlled antiretroviral drug release.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:17

    Topics: Anti-HIV Agents; Atazanavir Sulfate; Autophagy; beta-Cyclodextrins; Cell Survival; Clomipramine; Clonidine; Drug Carriers; Drug Interactions; Drug Liberation; HIV-1; Humans; Macrophages; Metformin; Nanoparticles; Particle Size; Pyridines; Pyrroles; Sirolimus; Tissue Distribution

2018